Immunology and Microbiology
Absorption
9%
Allele
61%
Allergen
9%
Antimicrobial Resistance
18%
Autoimmune Disease
16%
Autoimmunity
18%
Bacteriophage
11%
Blood Level
15%
Blood Plasma
32%
C-Reactive Protein
18%
Cell Death
12%
Central Nervous System
13%
Chromatography
9%
Chronic Fatigue Syndrome
100%
COVID-19
18%
Cytokine
19%
Diphtheria Antibody
13%
Dirofilaria repens
9%
DNA Conformation
9%
Drug Resistance
12%
Drug Sensitivity
13%
Echinococcosis
18%
ELISA
17%
Enterobacteriaceae
9%
Enzyme-Linked Immunosorbent Assay
9%
Fas Ligand
9%
Feces microflora
9%
Gastrointestinal Mucosa
9%
Gene Frequency
11%
Gene Sequence
13%
Genetic Distance
13%
Genetic Polymorphism
15%
Gram-Negative Bacteria
9%
Haplotype
16%
Hepatitis A Virus
9%
Hepatitis C
15%
Hepatitis C Virus
13%
Herpesviridae
14%
HLA DRB1 Antigen
15%
HLA-DQ
9%
HLA-DR
9%
Human Herpesvirus 6
46%
Human Herpesvirus 7
20%
Human Immunodeficiency Virus 1
13%
Human Immunoglobulin
12%
Human Leukocyte Antigen
34%
Human Parvovirus B19
18%
Immunoglobulin G4
10%
Immunoglobulin M Antibody
10%
Immunoreactivity
9%
Infectious Agent
17%
Inflammatory Bowel Disease
9%
Intercellular Adhesion Molecule 1
9%
Interferon Gamma
12%
Interleukin 10
18%
Interleukin 6
14%
Intestine Flora
9%
Legionella
21%
Legionella pneumophila
18%
Lineages
11%
Lipid Peroxidation
9%
Lung Ventilation
9%
Macrophage Migration Inhibition Factor
9%
Measles
18%
Measles Antibody
9%
Microbiome
29%
Microflora
22%
Microorganism
9%
Middle Ear
18%
Monkeypox Virus
9%
Multiple Sclerosis
9%
Mycobacterium Tuberculosis
47%
Myelopid
25%
Otitis Media
18%
Oxidative Stress
9%
Paraffin Embedding
9%
Polymerase Chain Reaction
9%
Prevalence
31%
Programmed Cell Death
9%
Promoter Region
9%
Pseudomonas aeruginosa
18%
Resistome
9%
Roseolovirus
9%
Scleroderma
9%
Seropositivity
12%
Seroprevalence
21%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Single Nucleotide Polymorphism
18%
Systemic Scleroderma
9%
Tick Borne Encephalitis Virus
13%
Tick-Borne Encephalitis
27%
Toxoplasma gondii
9%
Tumor Necrosis Factor
32%
Ulcerative Colitis
11%
Upper Respiratory Tract
9%
Veillonella
9%
Viral Load
23%
Wart Virus
9%
Whole Genome Sequencing
25%
Zoonotic
21%
Medicine and Dentistry
Actinic Keratosis
36%
Alcohol Liver Disease
10%
Allele
21%
Anemia
12%
Antioxidant
11%
Antiretroviral Therapy
9%
Apoplexy
31%
Autoimmune Disease
11%
Autoimmune Hepatitis
9%
Bacteriophage
13%
Biological Marker
16%
Bleeding
27%
Brain Ischemia
33%
Caprylic Acid
9%
Cardiopulmonary Bypass
10%
Central Nervous System
11%
Cerebral Hemorrhage
19%
Chronic Fatigue Syndrome
18%
Chronic Hepatitis C
10%
Chronic Kidney Disease
9%
Clinical Feature
20%
Combination Therapy
10%
Comorbidity
15%
Computer Assisted Tomography
17%
COVID-19
33%
Cross Sectional Study
22%
Dasabuvir
9%
Differential Diagnosis
22%
Disease Course
13%
Dizziness
11%
ECG Abnormality
9%
Enterobacteriaceae
9%
Enteropathy
19%
Enzyme Linked Immunosorbent Assay
9%
Gastroenterology
10%
Gene Frequency
11%
Glomerular Filtration Rate
11%
Group Trial
9%
Gut
10%
Headache
11%
Heart Surgery
18%
Hepatitis C
39%
Hepatitis C Virus
34%
Hepatitis C Virus Genotype 1
9%
Hepatitis Virus
9%
HLA-DRB1
10%
Human Immunodeficiency Virus
13%
Human Immunodeficiency Virus 1 Infection
12%
Hypochromic Anemia
9%
Interim Analysis
9%
Intestinal Permeability
13%
Iron Deficiency
10%
Liver Cirrhosis
17%
Liver Fibrosis
18%
Liver Graft
14%
Liver Injury
9%
Lung
11%
Lyme Borreliosis
21%
Magnetic Resonance Imaging
10%
Medical Record
12%
Meningoencephalitis
10%
Microbiome
22%
Miliary Tuberculosis
13%
Mixed Infection
10%
Mortality Rate
10%
Multidrug Resistant Tuberculosis
9%
Myasthenia gravis
9%
Mycobacterium Tuberculosis
25%
Myelopid
9%
National Institutes of Health Stroke Scale
9%
Necrosis
10%
Observational Study
10%
Odds Ratio
17%
Ombitasvir
9%
Outpatient
24%
Oxidative Stress
18%
P16
9%
Papillomavirus Infection
9%
Paritaprevir
9%
Peritonitis
9%
Plasminogen Activator Inhibitor-1
27%
Pneumococcal Infection
36%
Pneumococcus
14%
Polyneuropathy
18%
Prevalence
37%
Ribavirin
9%
Ritonavir
9%
RNA 16S
18%
Scleroderma
9%
Sepsis
27%
Serotype
29%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Systemic Scleroderma
9%
Tick Bite
9%
Tick Borne Encephalitis
39%
Tick Borne Encephalitis Virus
13%
Transient Ischemic Attack
18%
Troponin T
14%
Wart Virus
18%
Whole Genome Sequencing
13%
Pharmacology, Toxicology and Pharmaceutical Science
Actinic Keratosis
27%
Adult Respiratory Distress Syndrome
9%
Amoeba (Life Cycle Stage)
9%
Angiogenic Factor
9%
Antiinfective Agent
9%
Antimicrobial Resistance
26%
Antithrombotic Therapy
9%
Atrial Fibrillation
9%
Biological Marker
16%
Bleeding
12%
Bowen's Disease
9%
Brain Hematoma
9%
Brain Hemorrhage
12%
Brain Ischemia
47%
C Reactive Protein
27%
Case Fatality Rate
10%
Cerebrovascular Accident
18%
Chronic Fatigue Syndrome
9%
Chronic Obstructive Lung Disease
9%
Clinical Feature
12%
Colistimethate
29%
Combination Therapy
9%
Comorbidity
22%
Coronavirinae
10%
Creatinine
11%
Cross Sectional Study
9%
Cyclin D
9%
Dabigatran
9%
Dipeptidyl Carboxypeptidase
9%
Diphtheria
9%
Disease Course
12%
ECG Abnormality
9%
Elimination
19%
Enterococcus
9%
Enteropathy
12%
Enzyme-Linked Immunosorbent Assay
12%
Ethambutol
12%
Fas Ligand
9%
Fibrinolytic Agent
27%
Focused Ion Beam
11%
Genetic Predisposition
9%
Gram Negative Bacterium
9%
Hepatitis A Virus
9%
Hepatitis C
61%
Hepatitis C Virus
38%
HIV
13%
HLA DRB1 Antigen
13%
Human Immunodeficiency Virus Infection
13%
Human Immunoglobulin
9%
Idarucizumab
9%
Inflammation
16%
Interleukin 6
10%
Intestinal Permeability
13%
Lactate Dehydrogenase
10%
Legionella
9%
Liver Abscess
9%
Liver Cirrhosis
16%
Liver Fibrosis
18%
Liver Injury
18%
Lung Tuberculosis
28%
Macrophage Migration Inhibition Factor
9%
Measles
9%
Microflora
18%
Miliary Tuberculosis
13%
Mixed Infection
9%
Mortality Rate
14%
Multi-Drug-Resistant Tuberculosis
9%
Multiple Organ Failure
9%
Myasthenia gravis
9%
Mycobacterium Tuberculosis
31%
Necrosis
12%
Pathogen Clearance
9%
Penicillinase
9%
Plasminogen Activator Inhibitor 1
18%
Pneumococcal Infection
18%
Prevalence
54%
Pseudomonas aeruginosa
9%
Remdesivir
9%
Retrospective Study
12%
Ribavirin
9%
Rifampicin
20%
SARS Coronavirus
13%
Sepsis
38%
Squamous Cell Carcinoma
13%
Streptomycin
9%
Sudden Death
9%
Syndrome
9%
Therapeutic Drug Monitoring
22%
Tick Borne Encephalitis
18%
Tick Borne Encephalitis Virus
9%
Toxic Hepatitis
9%
Transient Ischemic Attack
18%
Troponin T
18%
Tuberculostatic Agent
21%
Tumor Necrosis Factor
18%
Ulcerative Colitis
18%
Vancomycin
26%
Virus Hepatitis
18%
Wet Macular Degeneration
9%
Wilson's Disease
9%